607 related articles for article (PubMed ID: 36645291)
1. Altered dietary salt intake for preventing diabetic kidney disease and its progression.
Hodson EM; Cooper TE
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006763. PubMed ID: 36645291
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Altered dietary salt intake for people with chronic kidney disease.
McMahon EJ; Campbell KL; Bauer JD; Mudge DW; Kelly JT
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD010070. PubMed ID: 34164803
[TBL] [Abstract][Full Text] [Related]
4. Altered dietary salt intake for preventing and treating diabetic kidney disease.
Suckling RJ; He FJ; Macgregor GA
Cochrane Database Syst Rev; 2010 Dec; (12):CD006763. PubMed ID: 21154374
[TBL] [Abstract][Full Text] [Related]
5. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
[TBL] [Abstract][Full Text] [Related]
6. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
[TBL] [Abstract][Full Text] [Related]
7. Altered dietary salt intake for people with chronic kidney disease.
McMahon EJ; Campbell KL; Bauer JD; Mudge DW
Cochrane Database Syst Rev; 2015 Feb; (2):CD010070. PubMed ID: 25691262
[TBL] [Abstract][Full Text] [Related]
8. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.
Brand A; Visser ME; Schoonees A; Naude CE
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015207. PubMed ID: 35944931
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
[TBL] [Abstract][Full Text] [Related]
10. Protein restriction for diabetic kidney disease.
Jiang S; Fang J; Li W
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014906. PubMed ID: 36594428
[TBL] [Abstract][Full Text] [Related]
11. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
13. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.
Graudal NA; Hubeck-Graudal T; Jurgens G
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004022. PubMed ID: 33314019
[TBL] [Abstract][Full Text] [Related]
14. Low dialysate sodium levels for chronic haemodialysis.
Dunlop JL; Vandal AC; Marshall MR
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011204. PubMed ID: 30646428
[TBL] [Abstract][Full Text] [Related]
15. Glucose targets for preventing diabetic kidney disease and its progression.
Ruospo M; Saglimbene VM; Palmer SC; De Cosmo S; Pacilli A; Lamacchia O; Cignarelli M; Fioretto P; Vecchio M; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010137. PubMed ID: 28594069
[TBL] [Abstract][Full Text] [Related]
16. Metformin for preventing the progression of chronic kidney disease.
El-Damanawi R; Stanley IK; Staatz C; Pascoe EM; Craig JC; Johnson DW; Mallett AJ; Hawley CM; Milanzi E; Hiemstra TF; Viecelli AK
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013414. PubMed ID: 38837240
[TBL] [Abstract][Full Text] [Related]
17. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
[TBL] [Abstract][Full Text] [Related]
18. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.
Graudal NA; Hubeck-Graudal T; Jurgens G
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004022. PubMed ID: 28391629
[TBL] [Abstract][Full Text] [Related]
19. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
